Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

compulsory licence

This page shows the latest compulsory licence news and features for those working in and with pharma, biotech and healthcare.

Amgen gets block on sales of Repatha rival in Germany

Amgen gets block on sales of Repatha rival in Germany

They also attempted to persuade the German authorities to issue a compulsory licence for Praluent, but that failed too.

Latest news

  • Buyers’ Club wants government support on Orkambi imports Buyers’ Club wants government support on Orkambi imports

    compulsory licensing) crown use licence, launch a large scale clinical trial and provide direct support for individuals using the buyers’ club. ... These would be aggressive moves against Vertex, with a ‘crown use’ licence representing an

  • Orkambi buyers’ club set up to gain access to cheaper versions Orkambi buyers’ club set up to gain access to cheaper versions

    The group wants the government to use its compulsory licensing laws, called Crown Use licence to bypass Vertex’s UK patents and procure these cheaper copies for use on the NHS. ... Earlier this year, health ministers more or less ruled out using the

  • UK patient activist group takes aim at Orkambi patent UK patient activist group takes aim at Orkambi patent

    Crown use is a little-known provision in UK law which allows the government to bypass patents and issue a compulsory licence on a medicine if there is deemed to be ... The push for compulsory licensing has been driven by a newly-formed patient activist

  • Bayer fails to overturn Nexavar compulsory licence in India Bayer fails to overturn Nexavar compulsory licence in India

    Natco Pharma allowed to sell cut-price version of cancer drug. Bayer's first attempt at overturning a compulsory license in India for its cancer drug Nexavar was knocked back yesterday ... Natco received the the compulsory licence in March 2012 on the

  • India's patents versus India's patients India's patents versus India's patients

    Alternatively, we might see more examples of compulsory licensing in India where a government allows a third party to produce a patented product without the consent of the patent owner. ... In a landmark decision earlier this year, India granted its

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis Buyers’ Club

    Just Treatment is also urging the UK government to override Vertex’s patent via compulsory licensing or Crown Use Licence.

  • Intellectual property threats in the BRIC markets Intellectual property threats in the BRIC markets

    Brazil, for example, used the threat of compulsory licensing to obtain discounts for various HIV drugs, before actually issuing a compulsory licence in 2007 for Stocrin. ... of the compulsory licence process for Herceptin, Sprycel and Ixempra,

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....

Quick links